Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Joe DiMaggio Children’s Hospital Unveils $166 Million Expansion of Its Free-Standing Facility to Meet Florida’s Increasing Pediatric Healthcare Needs


Joe DiMaggio Children’s Hospital offers a comprehensive scope of healthcare services and programs in a caring, compassionate setting designed specifically for children.

“Everything we do and every decision we make focuses on what is best for children and families in our community.”Caitlin Stella, Joe DiMaggio Children’s Hospital CEO

After 30 years providing highly specialized pediatric care in South Florida, Joe DiMaggio Children’s Hospital has now reached another milestone – the expansion of its Hollywood location from four to eight floors. The hospital’s growth allows Memorial Healthcare System to meet the continuous demand for specialized services with new surgical capabilities, treatments and patient/family programs added to its mix of already established offerings.

“Everything we do and every decision we make focuses on what is best for children and families in our community. We listen to our patients, their families, pediatricians and the community in general, and incorporate this feedback into our growth plans,” said Caitlin Stella, CEO of Joe DiMaggio Children’s Hospital. “Our delivery of care and development of new programs and services are aligned with our commitment to creating and maintaining the highest standards of care for children; the care that they deserve.”

Since its inception in 1992, Joe DiMaggio Children’s Hospital has experienced tremendous growth and has evolved into a specialized tertiary care facility for children. From 2,000 admissions that first year, the children’s hospital now manages more than 375,000 patient encounters annually. Its service area has stretched considerably, with patients seeking care from across the United States and the Caribbean. The hospital’s Pediatric Transport Team now transports almost 2,000 children in need of specialty care annually from other hospitals.

To continue to meet the healthcare needs of children and families, Joe DiMaggio Children’s Hospital is expanding from 180,000 square-feet to nearly 400,000 square-feet. In keeping with the hospital’s theme, Power of Play, the new floors – five through eight – are themed as: Imagine, Rhythm, Adventure and Grow, respectively.

“Innovation through technology, strategic partnerships and growth of our building and medical teams is imperative to meet our goal of providing high quality patient care in the safest environment possible,” said Dr. Ronald Ford, Chief Medical Officer of Joe DiMaggio Children’s Hospital. “For 30 years, we have not wavered from our mission. With this expansion, we are ushering in state-of-the-art technologies and new spaces designed with both the child and family in mind.”

For the first time in its history, the hospital will offer a neurosurgical operating suite with intraoperative magnetic resonance imaging (IMRI), a cutting-edge technology that offers real time magnetic resonance imaging (MRI) in a surgical environment. This IMRI technology is primarily used in neurosurgical procedures including tumor removals or placing implants during epilepsy surgeries with pinpoint precision. The MRI is a 3 Tesla strength magnet that is specialized for brain imaging. When clinically needed, the 20,000-pound MRI moves from the scan room into the neurosurgical operating suite along a ceiling-mounted transport system.

The hospital is also introducing a comprehensive cardiac care floor to optimize safety and quality, improve clinical outcomes and enhance the patient and family experience. The new 6th floor is designed to bring together complex procedures and specialized services in one location to minimize moving cardiac patients. The Helene and Stephen Weicholz Pediatric Cardiovascular Intensive Care Unit (CVICU) will house 20 cardiac ICU beds, a preoperative and recovery care area, and four state-of-the-art cardiac procedural suites with The Frederick A. DeLuca Foundation Cardiac Hybrid Operating Room, a hybrid operating room to perform cardiac catheterizations, electrophysiology (EP), interventional radiology (IR) and cardiothoracic open-heart surgeries.

On the 5th floor, the new Inpatient Rehabilitation Gym will feature several therapeutic rooms, a sensory room, a Virtual Reality treadmill, a Bioness Vector Gait & Safety System to provide additional support and safety when moving around the room, and access to the outdoor Hope Terrace, where patients can expand their inpatient rehabilitation journey to the outdoors. The inpatient rehabilitation nursing unit will consist of six large private rooms that will provide families with plenty of space during their admission. The expansion will allow the medical team to treat patients with more complex diagnoses who will benefit from an inpatient rehabilitation stay.

The expansion makes room for:


  • Joe DiMaggio Children’s Hospital Medical Staff Simulation Lab,
  • Patient classroom for ongoing education provided by Broward County Public Schools,
  • State-of-the-art private patient rooms designed with feedback from families about how they would best utilize the space,
  • General pediatric ICU,
  • Additional surgical and interventional radiology suites,
  • Dedicated pediatric pharmacy with patient safety innovations, including using DoseEdge to automate preparation, tracking and reporting of IV solutions and oral medications,
  • Center for Complex Care, an alliance with Boston Children’s Hospital
  • Playrooms and family lounges on each of the new floors including the Family Lounge on the 7th floor, a generous gift from UKG

The expansion project is a $166 million investment, with nearly a third of that amount being generated through community philanthropy. “Catch the Love,” a capital campaign undertaken by the Joe DiMaggio Children’s Hospital Foundation that set a fundraising goal of $56 million, has been well received by many that understand the importance of having an advanced children’s hospital close to home. Chaired by incoming foundation chair Brett Rose, the campaign has been aided by an ongoing effort from NHL star Aleksander “Sasha” Barkov. The Florida Panthers captain has, for the past three hockey seasons, donated $1,600 for each goal he scores and $800 for everyone he assists on, leading to nearly $215,000 in contributions to date.

Another celebrity that has left his mark on the expanded facility is Garth Brooks. The eighth floor is home to the nation’s 14th Garth Brooks Teammates for Kids Child Life Zone. The area, made possible, in part, by a generous donation from the Finker-Frenkel Family Foundation, features a daily itinerary of activities and exhibits for kids of all ages, expressive and therapeutic play areas, production space for in-house Joe D. TV, and open places to host yoga, music, art, and special events. It houses the Health and Wellness Teaching Kitchen and the City Furniture Family Lounge, where families can relax with their children in a safe environment that enables them to leave behind, at least temporarily, their hospital rooms. They can also enjoy that opportunity at the Lollipop Theater, sponsored by BBX Capital Foundation.

“There are few places nationwide where families can go to receive the highly specialized pediatric care that is closer to home than Joe DiMaggio Children’s Hospital. Regardless of a child’s age, medical complexity, or ability to pay – a team of experts is ready to help,” said Kevin Janser, CEO of Joe DiMaggio Children’s Hospital Foundation. “The hospital welcomes its growth to meet South Florida’s increasing pediatric healthcare needs.”

To learn more about the Joe DiMaggio Children’s Hospital expansion, visit https://www.jdch.com/give/expansion. For materials to assist editorial coverage, downloads are available at https://drive.google.com/drive/folders/1Z42OmSSBN-L7_vguyIP-PdPlX_CPjri_?usp=sharing.

# # #

Joe DiMaggio Children’s Hospital is one of the nation’s leading pediatric hospitals, offering a comprehensive scope of healthcare services and programs in a caring, compassionate setting designed specifically for children. A level one pediatric trauma center, the hospital, part of Memorial Healthcare System, combines advanced technology and the expertise of one of the largest and most diverse, groups of board-certified pediatric specialists in the region, with a focus on patient and family-centered care to heal the body, mind, and spirit.

To learn more, visit jdch.com and connect with @jdchospital on Facebook, Twitter, YouTube and Instagram.

The Healthcare Technology Report’s Top 25 Healthcare Technology COOs of 2022


The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology COOs of 2022. The companies represented on this year’s list are some of the most successful and innovative in the healthcare technology industry, and that is due in no small part to the efforts of their chief operating officers. These awardees have not only expertly overseen the day-to-day operations of their companies, but they have also crafted business strategies that have helped their organizations rise to the top amidst an industry inundated with competition.

Some of the distinguished COOs on this year’s list include Thomas Denny of the Duke Human Vaccine Institute, which together with the Center for HIV/AIDS Vaccine Immunology is working to develop vaccines and therapeutics for HIV and other emerging infections. Meanwhile, Chris Chi’s Monogram Health is providing an innovative renal care model and a data-driven array of clinical managed services, including complex case and disease management, utilization management, and medication therapy management. And Cue Health’s David Arida has helped the San Diego biotech research company launch major new testing offerings, with a novel molecular test for the flu and COVID-19 viruses currently awaiting FDA approval.

The awardees on this year’s list are responsible for running companies across healthcare technology. From vaccines to renal care, virus testing, cancer treatment, and pharmaceuticals, among many other specialties, these companies are addressing every aspect of patient health and well-being. Through their vital work, these COOs are helping to improve patient outcomes while at the same time operating massively successful companies. Please join us in celebrating The Top 25 Healthcare Technology COOs of 2022.

Ryan Fukushima (Tempus Labs, Inc.), Brady Shirley (Enovis), Michael Dingle (TELUS Health), Thomas Denny (Duke Human Vaccine Institute), Chris Chi (Monogram Health), David Arida (Cue Health), Chris Tovey (Jazz Pharmaceuticals), Matt Miller (The Oncology Institute), Jennifer Jarrett (Arcus Biosciences), Eric Venker (Roivant Sciences), Stephen Gillett (Verily), Will Abbott (Carbon Health), Jared Fix (Alto Pharmacy), Patrick Bilbo (Organogenesis), Melissa Baird (Hims & Hers Health), DB Kartik (CorEvitas, LLC), Dan Raffi (Sim&Cure), Blake Watterson (iFIT), Neil Owens (Medicure), Joseph Cucolo (Canary Medical), Erwin Estigarribia (InterVenn Biosciences), Melissa Teran (Alife Health), Mark Gilmartin (T-Pro), Nicolas Fauchoux (Biotrial), Mukul Jain (Senseonics).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

Quality Control of Vaccines and Other Pharmaceutical Preparations by Total Nitrogen Determination, Upcoming Webinar Hosted by Xtalks


In therapeutic protein production, it’s critical to control the level of proteins in the source material, intermediate and end products.

Protein-based therapeutics are widely used in prevention and treatment of diseases, such as cancers, diabetes and autoimmunity/inflammation. Therapeutic proteins include peptide hormones, monoclonal antibodies, cytokines, therapeutic enzymes, blood factors, vaccines and peptide antibiotics. In therapeutic protein production, it’s critical to control the level of proteins in the source material, intermediate and end products. Thus, total protein analysis is a method of choice. Here, the featured speaker will explore the quality control of vaccines and other pharmaceutical preparations.

In the featured study, the catalytic combustion method with chemiluminescence detection (CLD) was utilized for total protein analysis according to USP (1057) Method 7 and as described in the Pharm. Eur. Monograph 2.5.33, Method 7B. A simple, rapid and robust method was developed on the Analytik Jena multi N/C 2100S pharma — a Total Organic Carbon and Total Bound Nitrogen (TOC/TNb) analyzer specifically designed for pharmaceutical applications — to obtain total bound nitrogen. The TNb can be easily converted into total protein.

Vaccine and allergen extracts were analyzed in this study. The allergen extracts usually contain high percent of glycerol which makes protein analysis challenging. The result demonstrated no analytical interference from the high glycerol content.

Join this webinar to gain insights into total protein analysis, and quality control of vaccines and other protein-based therapeutics by total nitrogen determination.

Join Oliver Buettel, Director Product Management and Applications, Analytik Jena US LLC, for the live webinar on Thursday, November 3, 2022, at 10am EDT (3pm CET/EU-Central).

For more information, or to register for this event, visit Quality Control of Vaccines and Other Pharmaceutical Preparations by Total Nitrogen Determination.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

What Oncology Trials Look Like Now, Upcoming Webinar Hosted by Xtalks


Oncology trials have especially benefited with DCT practices.

The adoption of decentralized and agile clinical trials has increased exponentially over the past few years. As adoption accelerates, so do the possibilities that a decentralized clinical trial (DCT) enables. Oncology trials have especially benefited with DCT practices.

In this webinar, Dr. Shaalan Beg, MD, MS, Vice President, Oncology, at Science 37 will host a conversation with a group of industry leaders, discussing what current clinical research looks like with oncology trials. The panel will share the value that agile approaches deliver to patients, sponsors, sites and CROs — giving examples of how decentralized elements are incorporated in oncology trials today, and how the landscape will change in the years to come.

Register to learn what oncology trials look like now with the adoption of decentralized practices.

Join experts from Science 37, James Chase (moderator), Senior Director, Thought Leadership; Dr. Shaalan Beg, MD, MS, Vice President, Oncology; Dr. Aasma Shaukat, Professor of Gastroenterology and Medicine, NYU Grossman School of Medicine; and Andrew J., Mckenzie, PhD, Vice President, Personalized Medicine, Sarah Cannon for the live webinar on Thursday, November 3, 2022, at 11am EDT (4pm CET/EU-Central).

For more information, or to register for this event, visit Decentralization in Action: What Oncology Trials Look Like Now.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Bereaved Parents and Allies March on Nation’s Capitol with Empty Strollers and Demand Action to Address Nation’s Stillbirth Crisis


A woman holds a sign that reads "The Big PUSH to End Preventable Stillbirth" while hundreds of demonstrators push empty strollers towards the U.S. Capitol Building representing the 23,000 babies born still every year in the United States.

Families march empty strollers past Congress to demand an end to preventable stillbirth.

“Our babies may have been born into silence, but we will make their voices heard. Enough with the excuses. Enough with the inaction. Enough with shrugging our shoulders and telling parents they can have another baby. Because they can’t.” –Samantha Banerjee, Bereaved Mother

On Saturday, Oct. 15, 2022, Pregnancy & Infant Loss Awareness Day, PUSH for Empowered Pregnancy (PUSH) banded together on the National Mall with 50+ organizations including bereaved parents, medical providers, and other advocates on a mission to end preventable stillbirth and improve pregnancy outcomes in the United States. This historic march is the first time ever that bereaved parents along with allies across the maternal/infant health space have gathered en masse to raise awareness of the tragedy of stillbirth. Demonstrators pushed empty strollers past the steps of Congress to illustrate the devastating toll of the silent epidemic of stillbirth in the United States and called on our leaders across medicine, government, and community for change. According to the Centers for Disease Control and Prevention (CDC), 23,000 babies are born still every year in the United States (CDC Wonder Database). In addition to the main march in DC, thousands participated virtually and at Satellite Events across the U.S., including in Florida, Iowa, Colorado, Wisconsin, Virginia, New York, and more.

The CDC defines a stillbirth as the death of a baby in utero at or after 20 weeks of pregnancy. Many of these deaths are otherwise healthy babies and occur in normal, uneventful, low-risk pregnancies. The Big PUSH to End Preventable Stillbirth sought to alert the public that with better awareness and simple prevention strategies, a significant portion of these babies could be saved, especially those that occur in the 3rd trimester.


  • WHO: PUSH for Empowered Pregnancy & a Coalition of over 50 nonprofit organizations in maternal/infant health and perinatal bereavement
  • WHAT: A nationwide empty stroller march to raise awareness in honor of the 23,000 babies born still each year in the U.S. – the largest mass mobilization of bereaved families and stillbirth allies in history
  • WHERE: Thousands of families and advocates are expected to gather in DC, plus thousands more at satellite marches and participating virtually across the country
  • WHEN: Saturday, October 15th, 2022 – Pregnancy & Infant Loss Awareness Day
  • WHY: Research shows that thousands of these deaths are preventable. The United States is shamefully far behind our international peers in stillbirth reduction. Families demand change in the name of their babies who have died

“Two days before my due date in 2013, I walked into the hospital in labor thinking I was finally bringing home my baby girl. Instead, I walked out with empty arms and a lifetime of excruciating what-ifs,” says PUSH Executive Director Samantha Banerjee. “Every day, 65 U.S. families face the same brutal end to their otherwise normal and healthy pregnancies, and most of us never even heard the word ‘stillbirth’ before it happened to us. Families like mine were robbed of the chance to save our babies because no one ever bothered to inform us that stillbirth is a risk. In Alana’s name and that of the 23,000 other American children who die like her every year, we are demanding change.”

The event featured a powerful art installation consisting of 23,000 newborn hats, to represent the 23,000 babies who die every year. PUSH commissioned local DC artist, Ashley Jaye Williams, to craft the face of an anguished, screaming mother whose baby has been stillborn. The piece measures 30 feet high by 30 feet wide.

Dr. Joanne Stone, Chair of Obstetrics, Gynecology, and Reproductive Science for Icahn Mount Sinai and the Mount Sinai Health System, Founder of the Mount Sinai – Rainbow Clinic, and President of The Society for Maternal-Fetal Medicine (SMFM) spoke at the event. “Stillbirth has been often regarded by the medical community as something that ‘just happens’ rather than the life-altering tragedy it is. It is time for us to recognize that many causes of stillbirth are preventable. We need to raise the awareness that families of color and those from other marginalized groups, as well as those with certain underlying medical conditions, are at least twice as likely to suffer a stillbirth. It’s time for prenatal care in this country to step up and make ending preventable stillbirth a top priority.”

Stillbirth is intimately correlated with other adverse pregnancy outcomes, particularly maternal mortality and morbidity. The Black Maternal Health community has rallied to stand in solidarity with this event and cause, and to advocate for stillbirth prevention strategies, many of which will likewise help close the racial disparity gap in birth outcomes.

“The human experiences of birthing and being born are sacred rites of passage. They are essential to our current and future existence on this planet,” says Shawnee Benton-Gibson, mother to Shamony Makeba Gibson who died at the age of 30 as a result of preventable postpartum complications in 2019. Shawnee along with Shamony’s partner, Omari Maynard, star in the Sundance Film Festival winning documentary Aftershock and spoke at The Big PUSH. “When black and brown women and birthing people and their babies cannot rely on the care and covering that every member of society is entitled to, then we are all teetering on the edge of extinction.”

  • 23,000 babies are born still in the U.S. every year (1 in 170 pregnancies)
  • 65 babies are lost to stillbirth every day in the U.S. – that’s three kindergarten classes every single day
  • Stillbirth claims more children’s lives in the U.S. each year than prematurity, SIDS, car accidents, drowning, guns, fire, flu, poison, and listeria COMBINED (Graphic)
  • Black mothers are twice as likely to suffer a stillbirth, compared to other races (CDC Wonder)
  • Research shows that at least 25% of U.S. stillbirths are preventable; for term pregnancies (37+ weeks), that jumps to nearly half (47%) of stillbirths
  • In the first 10 years of the Count the Kicks campaign in Iowa (2008-2018), the state’s stillbirth rate decreased nearly 32% while the rest of the country remained relatively stagnant
  • Stillbirth is closely linked to maternal mortality and morbidity – mothers who deliver a stillborn baby are almost five times as likely to experience severe maternal complications
  • The U.S. ranks 48th out of 49 developed nations in annual rate of reduction (ARR) of stillbirth, and 183rd out of 195 countries worldwide (UNICEF). This is unacceptable.

PUSH for Empowered Pregnancy, Healthy Birth Day, Aaliyah in Action, MomsRising, March for Moms, National Birth Equity Collaborative (NBEC), Measure the Placenta, International Stillbirth Alliance, Pregnancy After Loss Support, ARIAH Foundation, and many other allies are joined together in the name of all babies born still to demand change. They are asking that stillbirth be explicitly included in the Title V Maternal and Child Health (MCH) Block Grant to encourage states to make stillbirth prevention a priority by educating families, and that Congress pass the bipartisan Stillbirth Health Improvement and Education (SHINE ) for Autumn Act, (S.3972/H.R.5487) led by Senator Cory Booker (D-NJ) and Senator Marco Rubio (R-FL). This critical piece of legislation will make vital steps to invest in research and data collection required to better understand stillbirth. The Coalition further implores our nation’s medical leaders including the American College of Obstetrics & Gynecology (ACOG) to form a Stillbirth Prevention Working Group to implement internationally proven stillbirth prevention protocols as part of standard prenatal care in the U.S. Furthermore, closing the disparity gap in birth outcomes between White and BIPOC families should be made an explicit objective of this effort.

The Big PUSH to End Preventable Stillbirth is generously supported by sponsors including Earth Mama Organics, BLVR, Nurses Choice, Mommy Labor Nurse, AWHONN, and several medical professionals and small businesses in communities across the United States.

—About PUSH for Empowered Pregnancy—

We’re on a mission to end preventable stillbirth, and we’re not taking no for an answer.

65 babies are dying in the second half of pregnancy every single day in the U.S. – that’s 23,000 each year, most of them otherwise healthy, and all of them deeply loved. Many of these babies were our babies, and many of them could have been saved.

PUSH for Empowered Pregnancy exists for one reason, and one reason alone: to cut the US stillbirth rate by 20% by the end of 2030, in half by 2050, and in time, eradicate all preventable stillbirths. We are a diverse coalition of bereaved parents from around the country, and we are working closely with trailblazing medical researchers, courageous doctors, and other hardworking allies to drive down the incidence of stillbirth in the United States over the next decade by any means necessary.

Through partnerships with health providers and aggressive awareness campaigns, we will empower every expectant family with the equitable, evidenced-based medical care and education they need to advocate for a healthy pregnancy, giving parents and babies the best possible chance to make it home safely together.

No family should have to endure what we have endured. We are saying ENOUGH.

#UnitedWePush For Families, For Babies. For Change.

Learn more at http://www.pushpregnancy.org // Details, photos & livestream recording of this event at http://www.thebigpushmarch.org // Follow @pushpregnancy on all social media platforms



BrightStar Care® Expands Its Corporate Footprint Coast to Coast with Latest BrightStar Owned Acquisitions


News Image

BrightStar Care, the leading nationwide home care and medical staffing franchise known for providing the highest standard of quality in-home care, announced today the acquisition of four new BrightStar Owned (BSO) locations bringing its number of company-owned agencies to 20. The latest four locations added to the BrightStar Owned umbrella are located in Arizona and South Carolina, bringing the brand’s company-owned footprint coast to coast.

BrightStar Owned acquired these four locations from former BrightStar Care franchisees Andy Ray and Frank Sanders. Ray’s former offices are in Gilbert and Mesa Arizona, and Sanders in Greenville and Spartanburg, South Carolina. These acquisitions showcase how the BrightStar Owned program complements the franchise network so well. BrightStar Care created this initiative to further the brand’s robust franchise network and benefit its franchisees by providing an easy transition for franchisees looking to sell their operation for another business venture, retire, or move to another level of the BrightStar Care business. Ray recently shifted from franchise owner to Chief Operating Officer of BrightStar Care in this case. Sanders was able to sell his location to focus on other business ventures and aspects of his life.

“As we continue to align with where the healthcare industry is heading, we are focused on expanding BrightStar Owned by acquiring well-established franchised agencies we can learn and grow from,” said Shelly Sun, Founder and CEO of BrightStar Care. “The information and key takeaways we’re getting from BSO are vital for the future success of our network as the market continues to change rapidly. Franchising is how we became a nationwide enterprise, and we will continue to put processes in place to ensure its longevity for years to come.”

“Ray and Sanders’ agencies truly delivered a higher standard of care within their communities and will be valuable additions to BrightStar Owned,” said Andrew Tarman, Senior Vice President of Operations at BrightStar Owned. “We are most excited to learn from the scale of these locations in Arizona and South Carolina. These agencies all function as well-oiled machines with streamlined back-office processes and unique skilled care offerings, making them prime locations for the BrightStar Owned platform.”

Two years ago, BrightStar Care had just three corporate-owned agencies in its arsenal. Now through BrightStar Owned in less than two years, the brand has expanded its corporate footprint to 20 agencies. BrightStar Owned was created to utilize agencies within its platform as testing sites for new technologies, marketing, and new payer relationships to advance the entire network. Like all BrightStar Owned locations, Ray and Sanders’ agencies will provide the BSO team with valuable insights that can be evolved and shared with the broader franchise network.

With these acquisitions, BrightStar Owned now has 20 agencies from coast to coast, with a presence in Alabama, Arizona, Florida, Illinois, Iowa, and South Carolina. For more information on BrightStar Care and the BrightStar Owned program, please visit http://www.brightstarcare.com.

About BrightStar Care:

Founded in 2002, BrightStar Care is a national home care agency with more than 365 franchised locations nationwide that provide medical and non-medical in-home care services to clients in their homes and supplemental care staff to businesses. BrightStar Care franchise agencies across the country employ over 15,000 caregivers and 5,700 registered nurses who oversee the care and safety of each individual client. BrightStar Care offers custom medical staffing solutions to corporate entities and holds national accounts with government agencies across distinct patient populations providing healthcare staff anywhere care is needed. Female founded and led by CEO Shelly Sun, BrightStar Care is committed to providing a higher standard of care through its clinical nurse-led care model. As a member of Moving Health Home, BrightStar Care also actively advocates to change federal and state policies that prevent the home from being an accredited clinical care site. More than 95% of BrightStar Care agencies are Joint Commission accredited – the gold standard within the health care industry. BrightStar Care has also been the only national home care franchise to consecutively receive The Joint Commission’s Enterprise Champion for Quality award for the past decade.

Share article on social media or email:

AAGL to Host Global Congress on Minimally Invasive Gynecologic Surgery, December 1-4, 2022


“The 2022 AAGL Global Congress is an incredible opportunity for learning and collaborating with colleagues from across the globe to advance progress in minimally invasive gynecologic surgery and to improve access to quality healthcare for all women.” Andrew I. Sokol, 2022 Scientific Program Chair.

AAGL Global Congress registration is filling at a record-breaking pace as the global association prepares to welcome physicians from all over the world online and at the Gaylord Rockies Convention Center in Aurora, Colorado, USA. The theme of this year’s Global Congress, “Dissemination of MIGS Care: Improving Access for All” captures AAGL’s global vision to combine the wealth of experience of our worldwide physicians and best identify ways to improve access to quality MIGS care for all women, including those in underserved populations.

This robust, four-day, scientific program, thoughtfully developed by Dr. Andrew I. Sokol and the Scientific Program Committee, includes CME (Continuing Medical Education) on all modalities of MIGS access, including 22 Postgraduate Courses, 12 Oral Sessions, 8 Panel Discussions, 6 Surgical Tutorials, 22 Luncheon Round Tables, a Virtual Poster area in the Exhibit Hall with narration from presenters, and 5 Pre-recorded and Live Surgeries. Attendees will receive training on topics such as Low-cost Vaginal Surgery, Endometriosis, Fibroids, Pelvic Pain, Nerve Sparing, Suturing, Oncology, Gender Affirmation Surgery, Disparities in Access to Care, vNOTES, Hysteroscopy, Laparoscopy, Robotics and more.

Six dynamic General Sessions punctuate the event and include the very popular AAGL MED Talks, pre-recorded surgeries, and this year’s Keynote Address Speaker, world renown community advocate, Dr. Rajiv J. Shah. Dr. Shah is President of the Rockefeller Foundation, former USAID Administrator, recipient of the Secretary of State’s Distinguished Service Award and the U.S. Global Leadership Award, and is a community advocate whose work has promoted the well-being of humanity around the world.

In addition to the exciting program line up, the AAGL Global Congress has fun social events and an engaging and interactive Exhibit Hall that provides an opportunity for device, pharmaceutical, and other medical technology companies to present their products and services to our attendees. Booths are staffed by knowledgeable industry representatives who also present product theaters and evening symposia to connect attendees with the latest innovations in the industry. There will also be a Suturing Competition headed by Dr. Charles H. Koh.

“The 2022 AAGL Global Congress is an incredible opportunity for learning and collaborating with colleagues from across the globe to advance progress in minimally invasive gynecologic surgery and to improve access to quality healthcare for all women.” Andrew I. Sokol, 2022 Scientific Program Chair and AAGL in-coming President.

As in years past, the AAGL Global Congress on MIGS is the premier academic event of the year for personal and professional development in Minimally Invasive Gynecologic Surgery. Registration and general information about the meeting are available at the AAGL Global Congress webpage.

“We are excited to welcome our members to this year’s Global Congress where we not only give them the tools they need to advance their skills, but also provide encouragement and inspiration as they meet with their peers in an invigorating education environment,” Linda Michels, AAGL Executive Director.

2022 AAGL Global Congress Highlight Video: https://youtu.be/tnfv5I1LLLg

About AAGL

AAGL is an international professional medical association of laparoscopic surgeons and the global leader in minimally invasive gynecologic surgery. AAGL’s mission is to elevate the quality and safety of health care for women through excellence in clinical practice, education, research, innovation, and advocacy. Since 1971, the AAGL has educated the world’s finest surgeons and facilitated a global exchange of information regarding gynecological breakthroughs and best practices to improve women’s health worldwide. Find out more about the AAGL at: http://www.aagl.org.

For more information, please contact Doreen Wiley, AAGL Marketing and Communications Manager, at 714-503-6208 or dwiley@aagl.org

Share article on social media or email:

Slone Partners Places Jason Myers and Carol Berry to the Board of Directors of InterVenn Biosciences


Slone Partners

Their wealth of combined experience in research and industry roles in genomics and personalized medicine will help support the strategic and operational advancement of InterVenn as we enter our next chapter of growth,” said Aldo Carrascoso, Co-Founder and CEO of InterVenn Biosciences.

Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Jason Myers, Ph.D. and Carol Berry to the Board of Directors of InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare.

Myers brings to the board more than 20 years of industry and research experience in commercializing innovative genomic tools and diagnostics. He currently serves as CEO of Sequencing Health, an electronic detection platform capable of applications in DNA sequencing, for example, where he also serves on the Board of Directors. Prior to joining Sequencing Health, Myers was President of Oncology leading the personalized medicine strategy at Invitae, a medical genomics company.

Berry joins the company with more than 25 years of industry experience in personalized medicine and diagnostics. She currently serves as the Senior Vice President and Chief Business Officer at CellCarta (formerly Caprion Bioscience Inc.), a specialized CRO laboratory focused on personalized medicine. Prior to joining CellCarta, Berry served as the Senior Vice President and General Manager of the genomics services division at Asuragen, a molecular diagnostics company.

“Jason Myers and Carol Berry are both tremendously talented and visionary leaders in healthcare diagnostics and personalized medicine with unique insights and perspectives that will prove tremendously valuable to the InterVenn Board of Directors at an exciting time in the company’s evolution,” said Slone Partners President Tara Kochis.

“We are very excited to continue to strengthen the InterVenn Board of Directors with the additions of Dr. Myers and Ms. Berry. Their wealth of combined experience in research and industry roles in genomics and personalized medicine will help support the strategic and operational advancement of InterVenn as we enter our next chapter of growth,” said Aldo Carrascoso, Co-Founder and CEO of InterVenn Biosciences. “We look forward to their contributions to the company and leveraging their collective expertise.”

Myers received a B.A.Sc. in Biochemistry and Molecular Biology from Colorado State University and a Ph.D. in Molecular Pharmacology from the Stanford University School of Medicine. Berry received a Bachelor of Science from Texas A&M University and an M.B.A. in Information Technology Management from the University of Dallas.

ABOUT SLONE PARTNERS

Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, medical device, and laboratory services companies. With national and global clients, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences and healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.

ABOUT INTERVENN BIOSCIENCES

InterVenn is a clinical technology company unlocking the value of glycoproteomics for the development of transformational healthcare solutions. The glycoproteome is a source of life-critical information about human biology that has the potential to significantly improve patient outcomes, but it has remained inaccessible due to its vast complexity. InterVenn is pioneering a new AI-powered platform to decode and unlock the potential of the glycoproteome at clinically meaningful scale for the first time in history. To optimize this entirely new dimension of biology, the company has developed a platform capable of producing a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and potentially therapeutics. InterVenn will contribute to making the new era of personalized, predictive, and preventative care a reality. For more information about InterVenn, visit http://www.intervenn.com.

Share article on social media or email:

Dr. Colin Campbell of 1st Care Medical Arts Named NJ Top Doc For 2022


Dr. Colin Campbell

Dr. Colin Campbell

Board-Certified Internist, Dr. Colin Campbell of 1st Care Medical Arts is committed to keeping South Jersey healthy…one patient at a time. He always treats his patients the way he would want to be treated, with kindness and a sense of humor.

If you are in need of a Primary Care Physician, who is able to see you in a timely fashion and personally sees you during every visit to manage all aspects of your healthcare needs, then Dr. Campbell is a perfect fit for you.

This NJ Top Doc continuously works day and night to deliver answers for all your health questions. Dr. Campbell makes it a priority to be there to help you make medical decisions with confidence and support all of your healthcare needs.

A few insurances accepted at 1st Care Medical Arts include Medicare, Aetna, Amerihealth, Cigna, Horizon, Blue Cross Blue Shield, and Humana. Dr. Campbell is always accepting new patients.

To learn more about Dr. Colin Campbell, please visit: https://njtopdocs.com/nj-doctors/colin-campbell/

—

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



CS Analytical Offers Comprehensive cGMP Cold Product Package System Qualification Program


Having the ability to design and implement a comprehensive qualification program for cold storage package systems that spans the full product lifecycle, from development to commercialization, is a prime example of what we strive to deliver at CS Analytical

CS Analytical Laboratory, the world’s only cGMP, FDA-regulated contract laboratory exclusively designed and dedicated to container and package testing and regulatory solutions for the pharmaceutical, biotechnology, and medical device industries, is pleased to introduce a new comprehensive service offering designed specifically for the qualification of product-package systems requiring cold storage at or below -60°C. This program, based on a holistic science-based approach according to industry best practices, is scalable to cover all stages of the product lifecycle. Services built into these comprehensive programs include:

USP / EP Qualification Testing Dimensional Analysis

  • Package Development
  • Stack-up Tolerance Analysis
  • Incoming Lot Inspection


USP 1207 Headspace Analysis

  • Method Development
  • Method Validation
  • Inherent Integrity Evaluation
  • Routine Analysis


Capping Optimization

  • Onsite Capping
  • Residual Seal Force Analysis
  • CCI Testing


Capping Line Qualification Transport Validation

  • ASTM and ISTA Distribution
  • CCI Pre- and Post-Test


Clinical Batch CCI

Stability Program CCI

“We are very excited to offer this type of program within our FDA regulated, cGMP facility,” noted Brandon Zurawlow, Chief Scientific Officer. “Having the ability to design and implement a comprehensive qualification program for cold storage package systems that spans the full product lifecycle, from development to commercialization, is a prime example of what we strive to deliver at CS Analytical. By seamlessly integrating services at key product-package and process development, validation, and routine testing phases, we can deliver a data package to our clients that is in line with current regulatory trends and best practices, and meets or exceeds all regulatory expectations.”

Cold storage products, such as cell or gene therapies, often require storage at temperatures below -20°C, and are involved in storage and distribution environments incorporating dry ice (~-80°C), or even liquid nitrogen (~-200°C). In many cases, the package systems in which these products are placed are rather traditional in nature, such as a threaded closure or crimp-top vial. However, many of the materials used in these package systems and responsible for maintaining package integrity are not typically intended for or assessed for leakage at these temperatures. When exposed to deep-cold or ultra-cold temperatures, physical changes to elastomeric components in particular can occur as materials reach or exceed their glass transition state, creating leaks at low temperatures that would otherwise not be observed while at room temperature. This type of leakage is typically observed at primary seal areas, such as that between an elastomeric closure and glass vial being used below -60°C.

The team at CS Analytical has leveraged its years of experience designing and implementing comprehensive qualification programs in addressing the market need of these new class of drugs requiring cold storage. The program can be performed as one comprehensive project that progresses with the product lifecycle starting in development, or specific test sections may be performed a-la-carte as the appropriate technology and general study approach is considered on a product-to-product basis, taking into account the regulatory need, intended storage and shipment conditions, product sensitivities, and lifecycle stage the analysis is being performed.

About CS Analytical Laboratory

The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and the thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic and elastomers as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Share article on social media or email: